YKL-40: A Novel Marker Shared by Chronic Inflammation and Oncogenic Transformation
YKL-40, a member of ‘mammalian chitinase-like proteins’, is secreted by macrophages, neutrophils, chondrocytes, endothelial-, vascular smooth muscle-, and cancer cells. High serum YKL-40 is a biomar-ker of poor prognosis in patients with cancer, inflammation and increased tissue remodelling. High YKL-40 protein expression assessed by immunohistochemistry is found in breast carcinomas associated with short disease-free survival and in glioblastomas with increased resistance to radiotherapy and decreased overall survival. In this chapter we describe the methods for the detection of (1 ) YKL-40 protein expression in human tissues (using immunohistochemistry) and cell cultures (using immunocytochemistry); (2 ) YKL-40 mRNA expression in human tissues (using in situ hybridization and Polymerase Chain Reaction); and (3 ) YKL-40 protein concentrations in serum or plasma (using Enzyme-Linked ImmunoSorbent Assay).
- EB病毒诱导淋巴细胞
- I1307K Mutation Detection by Allele-Specific PCR in Familial Colorectal Cancer
- Modulation of Apoptosis to Reverse Chemoresistance
- Obesity Provides a Permissive Milieu in Inflammation-Associated Carcinogenesis: Analysis of Insulin and IGF Pathways
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology
- SPR1: An Early Molecular Marker for Bronchial Carcinogenesis
- Matrix Metalloproteinase Expression in Lung Cancer
- Classification of AML Using a Monoclonal Antibody Microarray
- G418原代细胞的筛选
- Single-Domain VH Antibody Fragments from a Phage Display Library